CG
UTHR icon

Caprock Group’s United Therapeutics UTHR Stock Holding History

Caprock Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Sell
516
-113
-18% -$63.6K 0.01% 1054
2026
Q1 		$373K Buy
629
+20
+3% +$9.96K 0.01% 845
2025
Q4 		$297K Buy
+609
New +$284K 0.01% 1004
2025
Q1 		– Sell
-792
Closed -$279K – 1174
2024
Q4 		$279K Buy
792
+111
+16% +$40.8K 0.01% 832
2024
Q3 		$244K Sell
681
-13
-2% -$4.39K 0.01% 784
2024
Q2 		$221K Buy
+694
New +$184K 0.01% 782
2021
Q3 		– Sell
-1,406
Closed -$252K – 573
2021
Q2 		$252K Sell
1,406
-200
-12% -$38.1K 0.02% 428
2021
Q1 		$269K Hold
1,606
– – 0.03% 368
2020
Q4 		$244K Buy
+1,606
New +$211K 0.03% 387

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caprock Group's UTHR Position: Q2 2026 in Review

Caprock Group reduced its United Therapeutics (UTHR) stake by 18% in Q2 2026, selling an estimated $63.6K and leaving 516 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #1054.

Caprock Group first reported a position in UTHR in Q4 2020 and has held it in 9 quarters since. The position peaked at $373K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Caprock Group held 516 shares of United Therapeutics worth $280K as of Q2 2026.
  • Caprock Group sold 113 United Therapeutics shares in Q2 2026, an estimated $63.6K.
  • United Therapeutics made up 0.01% of Caprock Group's portfolio in Q2 2026, its #1054 holding.
  • Caprock Group first reported a position in United Therapeutics in Q4 2020 and has held it in 9 quarters since.
  • Caprock Group's United Therapeutics position peaked at $373K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.